In Vivo Rodent Studies with the Novel PET Tracer [18F]PGM028299: An Inhibitor of D-Amino Acid Oxidase
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.6c01035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Mayca Onega und 20 weiteren Autor:innen. Beteiligte Einrichtung: Imanova Ltd., Now Dba Perceptive Discovery, Burlington Danes Building, Hammersmith Hospital, Du Cane Road, LondonW12 0NN, U.K. Hauptthemen laut MEDLINE: D-Amino-Acid Oxidase, Positron-Emission Tomography, Fluorine Radioisotopes, Radiopharmaceuticals. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Abnormal N-methyl-d-aspartate receptor (NMDAr) function is implicated in schizophrenia and other neuropsychiatric disorders. Enhancing NMDAr signaling can be achieved by increasing synaptic d-serine levels through the inhibition of D-amino acid oxidase (DAAO). We report the synthesis and preclinical evaluation of [18F]2 ([18F]PGM028299), a novel PET radiotracer for imaging DAAO in the brain. Enzyme occupancy studies in rodents showed that [18F]2 is a displaceable ligand, with binding blocked dose dependently by the DAAO inhibitor luvadaxistat. Radiosynthesis was initially achieved via a copper-mediated radiofluorination. Subsequent optimization using a Sonogashira coupling strategy resulted in improved radiochemical yields. PET imaging studies demonstrated rapid brain uptake, with the highest retention observed in the cerebellum and brainstem, along with reversible tracer kinetics. Tracer kinetic modeling showed that specific binding was abolished following pharmacological challenge. Human dosimetry estimates indicated a favorable safety profile. These findings support [18F]2 as a promising PET tracer for in vivo DAAO imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Imanova Ltd., Now Dba Perceptive Discovery, Burlington Danes Building, Hammersmith Hospital, Du Cane Road, LondonW12 0NN, U.K.
- Takeda Cambridge Ltd. , 418 Cambridge Science Park, Milton Road, Cambridge, CambridgeshireCB4 0PA, U.K.
- Perceptive Discovery, Burlington Danes Building, Hammersmith Hospital, Du Cane Road, LondonW12 0NN, U.K.
- Takeda Development Center Americas, Inc., One Takeda Parkway, Deerfield, Illinois60015, United States.
ORCID-Profile: Matt Barnes, Christophe Plisson
Zitieren
APA
Onega, M., Howley, E., Fieldhouse, C., Almond, S., Farnaby, W., Kerr, C., Mitchell, P., Fradley, R., Patel, T., Barnes, M., Coello, C., Gunn, R. N., Keat, N., Ashworth, S., Tang, S. P., Wells, L. A., Rabiner, E. A., Passchier, J., Tauscher, J., …, & Plisson, C. (2026). In Vivo Rodent Studies with the Novel PET Tracer [18F]PGM028299: An Inhibitor of D-Amino Acid Oxidase. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01035
Vancouver
Onega M, Howley E, Fieldhouse C, Almond S, Farnaby W, Kerr C, et al. In Vivo Rodent Studies with the Novel PET Tracer [18F]PGM028299: An Inhibitor of D-Amino Acid Oxidase. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01035
BibTeX
@article{Onega2026,
author = {Onega, Mayca and Howley, Eimear and Fieldhouse, Charlotte and Almond, Sarah and Farnaby, William and Kerr, Catrina and Mitchell, Philip and Fradley, Rosa and Patel, Toshal and Barnes, Matt and Coello, Christopher and Gunn, Roger N and Keat, Nicholas and Ashworth, Sharon and Tang, Sac-Pham and Wells, Lisa A and Rabiner, Eugenii A and Passchier, Jan and Tauscher, Johannes and Miller, David and Plisson, Christophe},
title = {In Vivo Rodent Studies with the Novel PET Tracer [18F]PGM028299: An Inhibitor of D-Amino Acid Oxidase},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c01035}
}
EUVIMED